3 research outputs found

    Bํ˜• ๊ฐ„์—ผ ๋ฐ”์ด๋Ÿฌ์Šค ์œ ์ „์žํ˜• C์˜ ์—ญ์ „์‚ฌํšจ์†Œ ๋‚ด rtL269I ๋ณ€์ด์ฃผ์˜ ์ œ 1ํ˜• ์ธํ„ฐํŽ˜๋ก  ์‹ ํ˜ธ์ „๋‹ฌ์„ ํ†ตํ•œ HBeAg ์Œ์„ฑ ๊ฐ์—ผ ๋ฐ ๊ฐ„์งˆํ™˜ ์•…ํ™”๊ธฐ์ „์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ(๋ฐ•์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :์˜๊ณผ๋Œ€ํ•™ ์˜ํ•™๊ณผ,2020. 2. ๊ตญ์œคํ˜ธ.Background and Aims: Hepatitis B virus infection is a serious global health problem and causes life-threatening liver disease. In particular, genotype C shows high prevalence and sever liver disease compared with other genotypes. However, the underlying mechanisms regarding virological traits still remain unclear. This study investigated the clinical factors and capacity to modulate Type I interferon (IFN-I) between two HBV polymerase polymorphisms rt269L and rt269I in genotype C. Methods: The clinical factors between rt269L and rt269I in 220 Korean chronic patients with genotype C2 infections were compared. The prevalence of preC mutations between rt269L and rt269I was compared using this cohort study and the GenBank database. For in vitro study, plasmid DNA encoding HBV genome were transiently transfected into hepatocytes, and HBV virions were infected using HepG2-hNTCP-C4 and HepaRG systems. In addition, hydrodynamic injection of HBV genome into mice tail were conducted for in vivo experiments. Results: The clinical cohort study indicated that rt269I was related to HBV e antigen (HBeAg) negative serostatus, lower levels of HBV DNA and HBsAg, and disease progression compared to rt269L. Furthermore, the epidemiological study showed that HBeAg negative infections of rt269I were attributed to a higher frequency of preC mutations at 1896 (G to A). In vitro and in vivo study also suggested that rt269I caused mitochondrial stress mediated STING dependent IFN-I production, resulting in decreasing HBV replication via the induction of heme-oxygenase-1. In addition, I also found that rt269I enhanced iNOS mediated NO production in an IFN-I dependent manner. Conclusion: In this study, I found that there are two polymorphisms at polymerase RT region, rt269L and rt269I, in patients infected with genotype C, which is only found in genotype C. These data demonstrated that rt269I can contribute to HBeAg negative infections and liver disease progression in chronic patients with genotype C infections via mitochondrial stress mediated IFN-I production.Bํ˜• ๊ฐ„์—ผ ๋ฐ”์ด๋Ÿฌ์Šค๋Š” ์„ธ๊ณ„์ ์œผ๋กœ ์‹ฌ๊ฐํ•œ ๊ฐ์—ผ์„ฑ ์งˆํ™˜์„ ์œ ๋ฐœํ•˜๋ฉฐ, ํŠนํžˆ Bํ˜• ๊ฐ„์—ผ ๋ฐ”์ด๋Ÿฌ์Šค์— ์˜ํ•œ ๋งŒ์„ฑ ๊ฐ์—ผ์€ ์ƒ๋ช…์„ ์œ„ํ˜‘ํ•˜๋Š” ๊ฐ„์งˆํ™˜์„ ์ผ์œผํ‚จ๋‹ค. ๊ทธ ์ค‘ ์œ ์ „์žํ˜• C๋Š” ๋‹ค๋ฅธ ์œ ์ „์žํ˜•์— ๋น„ํ•ด ๋†’์€ ๋ณ‘์›์„ฑ, ํ•ญ๋ฐ”์ด๋Ÿฌ์Šค์ œ์ œ ์น˜๋ฃŒ์˜ ์–ด๋ ค์›€, ์ธํ„ฐํŽ˜๋ก  ์•ŒํŒŒ ์น˜๋ฃŒ์˜ ์ €ํ•ญ์„ฑ ๋ฐ ๊ฐ„์งˆํ™˜ ์•…ํ™”์˜ ๊ธ‰์†ํ•œ ์ง„ํ–‰ ๋“ฑ์˜ ํŠน์„ฑ์ด ๊ด€์ฐฐ๋˜์—ˆ๋‹ค. ์ด๋Ÿฌํ•œ ํŠน์„ฑ์€ ์œ ์ „์žํ˜• C์—์„œ๋งŒ ๋ฐœ๊ฒฌ๋˜๋Š” ์—ฌ๋Ÿฌ ์œ ์ „์ž ๋ณ€์ด์ฃผ ๋ฐ ์œ ์ „์ž ๋‹คํ˜•์„ฑ์— ๊ธฐ์ธํ•  ๊ฐ€๋Šฅ์„ฑ์„ ์ œ์‹œํ•˜๋Š” ์—ฐ๊ตฌ๊ฐ€ ๋ณด๊ณ ๋˜์—ˆ์œผ๋‚˜, ํŠน์„ฑ๊ณผ ๊ด€๋ จ๋œ ๊ทผ๋ณธ์ ์ธ ๊ธฐ์ „์€ ์—ฌ์ „ํžˆ ๋ถ„๋ช…ํ•˜๊ฒŒ ๋ฐํ˜€์ง„ ๋ฐ” ์—†๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ์œ ์ „์žํ˜• C์—์„œ HBV ์ค‘ํ•ฉํšจ์†Œ ๋‚ด ์—ญ์ „์‚ฌ ํšจ์†Œrt269L๋ถ€์œ„์˜ ๋‘๊ฐ€์ง€ ๋‹คํ˜•์„ฑ (rt269L๊ณผ rt269I) ์‚ฌ์ด์˜ ์ œ 1ํ˜• ์ธํ„ฐํŽ˜๋ก  (IFN-I)์„ ์กฐ์ ˆํ•˜๋Š” ํŠน์„ฑ๊ณผ ๊ฐ์—ผ ํ™˜์ž์˜ ์ž„์ƒ์  ์š”์ธ์„ ํ™•์ธํ•˜์˜€๋‹ค. ์ด๋ฅผ ์œ„ํ•˜์—ฌ ๊ตญ๋‚ด ์œ ์ „์žํ˜• C rt269L๊ณผ rt269I์— ๊ฐ์—ผ๋œ ํ™˜์ž 220๋ช… ์‚ฌ์ด์˜ ์ž„์ƒ์  ์š”์ธ์„ ๋น„๊ตํ•˜์˜€์œผ๋ฉฐ, ๊ฐ์—ผํ™˜์ž ๋ฐ GenBank ๋ฐ์ดํ„ฐ ๋ฒ ์ด์Šค๋ฅผ ์ด์šฉํ•˜์—ฌ ๋‘ ๋‹คํ˜•์„ฑ ์‚ฌ์ด์˜ preC ๋Œ์—ฐ๋ณ€์ด ๋นˆ๋„๋ฅผ ๋ถ„์„ํ•˜์˜€๋‹ค. ๋˜ํ•œ ์ž„์ƒ์  ํŠน์„ฑ์˜ ์›์ธ์„ ๊ทœ๋ช…ํ•˜๊ธฐ ์œ„ํ•˜์—ฌ C57BL/6 ๋งˆ์šฐ์Šค ๋ฐ ๊ฐ„์•”์„ธํฌ ๋ชจ๋ธ์—์„œ ๊ฐ์—ผ์‹œํ‚จ ํ›„ ๋ฐ”์ด๋Ÿฌ์Šค ๋ณต์ œ ์–‘์ƒ, ์ œ 1ํ˜• ์ธํ„ฐํŽ˜๋ก  ์‹ ํ˜ธ ๊ธฐ์ „ ๋ฐ ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ์ŠคํŠธ๋ ˆ์Šค, ํ™œ์„ฑ์งˆ์†Œ ๋“ฑ์„ ๋น„๊ต ๊ด€์ฐฐํ•˜์˜€๋‹ค. ๋ณธ ์—ฐ๊ตฌ์˜ ์ž„์ƒ ๋ฐ์ดํ„ฐ๋ฅผ ํ†ตํ•˜์—ฌrt269I ๋ณ€์ด์ฃผ๊ฐ€ rt269L์— ๋น„ํ•˜์—ฌ ํ˜ˆ์ฒญ ๋‚ด ์™ธํ”ผํ•ญ์› (HBeAg) ์Œ์„ฑ๊ฐ์—ผ, ๋‚ฎ์€ ์ˆ˜์ค€์˜ HBV DNA์™€ ํ‘œ๋ฉดํ•ญ์› (HBsAg), ๊ทธ๋ฆฌ๊ณ  ์งˆ๋ณ‘์˜ ์•…ํ™”๋ฅผ ์•ผ๊ธฐํ•˜๋Š” ๊ฒƒ์„ ํ™•์ธํ•˜์˜€๋‹ค. ์ด๋Ÿฌํ•œrt269I ๊ฐ์—ผ์— ์˜ํ•œ ์™ธํ”ผํ•ญ์› ์Œ์„ฑ๊ฐ์—ผ์€ preC ๋‚ด 1896๋ฒˆ์งธ ๋‰ดํด๋ ˆ์˜คํ‹ฐ๋“œ๊ฐ€ ๊ตฌ์•„๋‹Œ์—์„œ ์•„๋ฐ๋…ธ์‹ ์œผ๋กœ ๋Œ์—ฐ๋ณ€์ด๊ฐ€ ์ƒ๊ฒจ ์ผ์–ด๋‚˜๋Š” ๊ฒƒ์ž„์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋˜ํ•œ ์‹œํ—˜๊ด€ ๋‚ด ๋ฐ ์ƒ์ฒด ๋‚ด ์—ฐ๊ตฌ์—์„œ๋Š” rt269I๊ฐ€ ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ์ŠคํŠธ๋ ˆ์Šค ๋งค๊ฐœ ์ œ 1ํ˜• ์ธํ„ฐํŽ˜๋ก  ์ƒ์„ฑ์„ ์œ ๋„ํ•˜์—ฌ ํž˜์˜ฅ์‹œ๊ฒŒ๋‚˜์ œ (heme oxygenase)-1์˜ ๋ฐœํ˜„์„ ์ฆ๊ฐ€์‹œํ‚ค๊ณ , ๊ทธ ๊ฒฐ๊ณผ HBV ๋ณต์ œ๋ฅผ ๊ฐ์†Œ์‹œํ‚ฌ ์ˆ˜ ์žˆ๋‹ค๋Š” ๊ฒƒ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋˜ํ•œ, rt269I ๋ณ€์ด์ฃผ๊ฐ€ ์ œ 1ํ˜• ์ธํ„ฐํŽ˜๋ก  ์˜์กด์ ์ธ ๋ฐฉ์‹์œผ๋กœ ์‚ฐํ™”์งˆ์†Œํ™œ์„ฑํšจ์†Œ (inducible nitric oxide synthase) ๋งค๊ฐœ ํ™œ์„ฑ์งˆ์†Œ ์ƒ์‚ฐ์„ ํ–ฅ์ƒ์‹œํ‚ฌ ์ˆ˜ ์žˆ๋‹ค๋Š” ๊ฒƒ์„ ๋ฐœ๊ฒฌํ•˜์˜€๋‹ค. ์ด ์—ฐ๊ตฌ๋ฅผ ํ†ตํ•ด HBV ์ค‘ํ•ฉํšจ์†Œ ๋‚ด ์—ญ์ „์‚ฌํšจ์†Œ ๋ถ€์œ„์—๋Š” ์œ ์ „์žํ˜• C์—์„œ๋งŒ ๋ฐœ๊ฒฌ๋˜๋Š” rt269L๊ณผ rt269I ๋‘๊ฐ€์ง€ ๋‹คํ˜•์„ฑ์ด ์žˆ์Œ์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ, ์ด ์—ฐ๊ตฌ์˜ ๊ฒฐ๊ณผ๋Š” rt269I ๋ณ€์ด์ฃผ๊ฐ€ ๋ฏธํ† ์ฝ˜๋“œ๋ฆฌ์•„ ์ŠคํŠธ๋ ˆ์Šค ๋งค๊ฐœ๋ฅผ ํ†ตํ•ด ์ œ 1ํ˜• ์ธํ„ฐํŽ˜๋ก ์„ ์ƒ์‚ฐํ•˜๊ณ , ์ด ๊ธฐ์ „์ด ๋งŒ์„ฑ๊ฐ์—ผ ํ™˜์ž์—์„œ ์™ธํ”ผํ•ญ์› ์Œ์„ฑ๊ฐ์—ผ๊ณผ ๊ฐ„ ์งˆํ™˜ ์•…ํ™”์— ์˜ํ–ฅ์„ ์ค„ ์ˆ˜ ์žˆ์Œ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค.CONTENTS INTRODUCTION .. 1 MATERIALS AND METHODS 8 1. Patients 8 2. HBV DNA extraction and PCR amplification for polymerase RT region 8 3. HBV genotyping 8 4. Plasmid and site-directed mutagenesis 9 5. Cell culture and transfection 9 6. In vivo and hydrodynamic injection 10 7. Enzyme-linked immunosorbent assay 10 8. Covalently closed circular DNA extraction and real-time polymerase chain reaction 11 9. Total RNA extraction and real-time polymerase chain reaction 13 10. IFN-I luciferase reporter assay 13 11. IFN-I signal block assay 13 12. Preparation of HBV from transiently transfected cells and Infection assay 14 13. Flow cytometry and Confocal analysis 14 14. 8-OHdG ELISA assay 14 15. Measurement of NO2- and NO3- levels 15 16. Statistical Analyses 15 RESULTS 16 1. rt269I was related to enhanced disease progression in a Korean cohort with genotype C infections. 16 2. The higher frequency of preC mutation (G1896A) in patients with rt269I infections was responsible for the higher frequency of HBeAg negative infections. 21 3. rt269I led to lower levels of HBV replication in in vitro and in vivo experiments. 23 4. Hepatocytes activated IFN-I signaling against rt269I infection. 28 5. The reduced replication capacity and enhanced IFN-I expression of rt269I were also proved in two HBV infection models. 37 6. The replication of rt269I was inhibited via STING- IFN-I axis. 41 7. rt269I enhanced mitochondrial stress mediated IFN-I production and heme oxygenase-1. 44 8. rt269I enhanced iNOS dependent NO production. 52 DISCUSSION 58 REFERENCES 65 ๊ตญ๋ฌธ์ดˆ๋ก 74 LIST OF TABLES Table 1. Definition of HBV mutation and polymorphism at reverse transcriptase based on database and cohort data 7 Table 2. PCR primers used for this study. 12 Table 3. Comparison of the clinical features between patients infected with the two types of genotype C, rt269L and rt269I. 20 Table 4. The frequencies of BCP and preC mutations between rt269L and rt269I in a Korean cohort and from reference strains. 22 LIST OF FIGURES Figure 1. Phylogenetic analyses of 1,032-bp polymerase RT sequences showed that the representative 20 patients used in cohort study belonged to genotype C. 18 Figure 2. The viral replication of rt269I was restricted in vivo infection model. 24 Figure 3. rt269I reduced viral replication in vitro analyses. 25 Figure 4. The viral replication of rt269I was reduced viral replication in vitro transient transfection system. 26 Figure 5. rt269I enhanced IFN-I production in in vivo assay. 30 Figure 6. Hepatocytes increased transcription level of IFN-I against rt269I infection. 32 Figure 7. HepG2 cells activated IFN-I signaling pathway and produced IFN-I against rt269I. 34 Figure 8. IFN-I production was enhanced in hepatocytes infected with rt269I. 36 Figure 9. The reduced replication capacity of rt269I was shown in HBV infection models. . 39 Figure 10. The replication inhibition found in rt269L was mediated via STING-IFN-I axis 42 Figure 11. HepG2 cells enhanced HO-1 in transcription and translation level against rt269I infection. 46 Figure 12. rt269I induced mitochondrial reactive oxygen species production. 48 Figure 13. rt269I caused mitochondrial stress in infected hepatocytes. 50 Figure 14. rt269I enhanced iNOS dependent NO production. 54 Figure 15. rt269I enhanced iNOS dependent NO production in IFN-I dependent manner. 56 Figure 16. Schematic presentation indicating distinct mitochondrial stress mediated IFN-I production and its distinct contribution to disease progression in chronic patients with genotype C infections between rt269L and rt269I. 63Docto

    Novel genetic variants of Hepatitis B Virus in fulminant hepatitis

    Get PDF
    Fulminant hepatitis (FH) is a life-threatening liver disease characterised by intense immune attack and massive liver cell death. The common precore stop codon mutation of hepatitis B virus (HBV), A1896, is frequently associated with FH, but lacks specificity. This study attempts to uncover all possible viral nucleotides that are specifically associated with FH through a compiled sequence analysis of FH and non-FH cases from acute infection. We retrieved 67 FH and 280 acute non-FH cases of hepatitis B from GenBank and applied support vector machine (SVM) model to seek candidate nucleotides highly predictive of FH. Six best candidates with top predictive accuracy, 92.5%, were used to build a SVM model; they are C2129 (85.3%), T720 (83.0%), Y2131 (82.4%), T2013 (82.1%),K2048 (82.1%), and A2512 (82.1%). This model gave a high specificity (99.3%), positive predictive value (95.6%), and negative predictive value (92.1%), but only moderate sensitivity (64.2%).We successfully built a SVM model comprising six variants that are highly predictive and specific for FH: four in the core region and one each in the polymerase and the surface regions. These variants indicate that intracellular virion/core retention could play an important role in the progression to FH

    Variability of the S gene of hepatitis B virus in southeastern China

    No full text
    In a study of 315 HBV specimens obtained from southern China, 240 (76.9%) were assigned to genotype B, 72 (22.9%) were genotype C, two (0.6%) were genotype A and one (0.3%) was genotype D. Statistical analysis revealed that variables such as age, gender, HBV vaccination rate, hepatitis anamnesis rate, anti-HBs and HBeAg prevalence and virus load were insignificant between genotype B (n = 240) and genotype C cases (n = 72) (P > 0.05). However, the frequency of amino acid (aa) substitutions in the major hydrophilic region (MHR; aa 99-169) and the putative HLA class I-restricted cytotoxic T lymphocyte (CTL) epitope region of the S gene, as well as the overlapping polymerase/RT region (aa 32-212), were significantly higher in genotype C group than genotype B (P < 0.001). These results suggest that the higher variability within genotype C carriers may account for the pathogenic potential.Science Foundation of the Fujian Province, China [2008-59-4]; Key Programs for Science and Technology of serious diseases of Xiamen City, China [WKZ0501]; Excellent Youth Foundation of Fujian Scientific Committee [2009J06020]; Key Special Subjects of Infectious Diseases [2008ZX10002-011/2008ZX10002-012
    corecore